Circulating Y-RNAs as New Players in Parkinson Disease and Their Associations with Clinical Measures

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss, and current therapies provide only symptomatic relief. Extracellular vesicles (EVs) have emerged as potential mediators of disease-modifying effects through the transfer of proteins, lipids, and non-coding RNAs. Y-RNAs, a conserved yet understudied class of small non-coding RNAs enriched in EVs, are implicated in fundamental cellular processes such as DNA replication, RNA stability, RNA quality control, and stress-response pathways, and may reflect disease-related cellular states, particularly given that some Y-RNA species are primate-specific. This study aimed to characterize Y-RNA expression in human neural cell models, determine how intracellular levels relate to EV-enriched extracellular profiles, and assess whether serum EV-enriched Y-RNAs show PD-associated alterations with diagnostic relevance and associations with clinical status. Methods: Human neural stem cells and malignant neural cell models were profiled for intracellular Y-RNA expression and EV-enriched extracellular Y-RNAs using EV-enriched RNA preparations. Serum samples from individuals with PD and healthy controls were analyzed to quantify circulating EV-enriched Y-RNAs. Relative Y-RNA abundance and pairwise relative Y-RNA expression measures were compared across cellular models, EV-enriched fractions, and clinical samples to identify disease-related patterns. Results: Y-RNAs displayed distinct relative expression patterns across neural cell models. EV-enriched profiles differed markedly from intracellular abundance, with consistent enrichment of RNY4 and depletion of RNY1 in EV-enriched fractions. These intracellular–extracellular differences were preserved in vesicles released under baseline conditions. In serum EV-enriched fractions, PD was associated with a specific Y-RNA signature: RNY3 related to disease presence, whereas RNY5 correlated with disease duration and severity. Pairwise relative Y-RNA expression measures also provided biologically informative signals both in cell models and patient samples. Conclusions: EV-enriched Y-RNA profiles diverge from intracellular patterns and h exploratory clinical relevance in PD, supporting their potential as markers of disease severity and contributors to disease-related molecular communication.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-13
DOI
https://doi.org/10.3390/cimb48111212
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Circulating Y-RNAs as New Players in Parkinson Disease and Their Associations with Clinical Measures

Chitra Venugopal, Sheila Kumari Singh, Aistė Pranckevičienė, Andrius Radžiūnas et al.
Current Issues in Molecular Biology
Extracellular vesicles in disease
article

Circulating Y-RNAs as New Players in Parkinson Disease and Their Associations with Clinical Measures

Chitra Venugopal, Sheila Kumari Singh, Aistė Pranckevičienė, Andrius Radžiūnas, Daina Skiriutė, Giedrius Steponaitis, Paulina Vaitkienė, Violeta Belickienė, Greta Žvinakytė, Zbigniev Balion
article en

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss, and current therapies provide only symptomatic relief. Extracellular vesicles (EVs) have emerged as potential mediators of disease-modifying effects through the transfer of proteins, lipids, and non-coding RNAs. Y-RNAs, a conserved yet understudied class of small non-coding RNAs enriched in EVs, are implicated in fundamental cellular processes such as DNA replication, RNA stability, RNA quality control, and stress-response pathways, and may reflect disease-related cellular states, particularly given that some Y-RNA species are primate-specific. This study aimed to characterize Y-RNA expression in human neural cell models, determine how intracellular levels relate to EV-enriched extracellular profiles, and assess whether serum EV-enriched Y-RNAs show PD-associated alterations with diagnostic relevance and associations with clinical status. Methods: Human neural stem cells and malignant neural cell models were profiled for intracellular Y-RNA expression and EV-enriched extracellular Y-RNAs using EV-enriched RNA preparations. Serum samples from individuals with PD and healthy controls were analyzed to quantify circulating EV-enriched Y-RNAs. Relative Y-RNA abundance and pairwise relative Y-RNA expression measures were compared across cellular models, EV-enriched fractions, and clinical samples to identify disease-related patterns. Results: Y-RNAs displayed distinct relative expression patterns across neural cell models. EV-enriched profiles differed markedly from intracellular abundance, with consistent enrichment of RNY4 and depletion of RNY1 in EV-enriched fractions. These intracellular–extracellular differences were preserved in vesicles released under baseline conditions. In serum EV-enriched fractions, PD was associated with a specific Y-RNA signature: RNY3 related to disease presence, whereas RNY5 correlated with disease duration and severity. Pairwise relative Y-RNA expression measures also provided biologically informative signals both in cell models and patient samples. Conclusions: EV-enriched Y-RNA profiles diverge from intracellular patterns and h exploratory clinical relevance in PD, supporting their potential as markers of disease severity and contributors to disease-related molecular communication.

Current Issues in Molecular BiologyVol. 48(11)
Lithuanian University of Health Sciences (LT), McMaster University Medical Centre (CA), McMaster University (CA)
Lietuvos Mokslo Taryba
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon